Kanna Extract and VMAT2: Understanding the Relationship

Kanna Extract and VMAT2: Understanding the Relationship

Kanna extract, derived from Sceletium tortuosum, has been traditionally used for its mood-enhancing properties. Recent discussions have focused on its interaction with the vesicular monoamine transporter 2 (VMAT2), a protein responsible for transporting neurotransmitters like dopamine, serotonin, and norepinephrine into synaptic vesicles. Understanding this interaction is crucial for comprehending how kanna extract influences mood and cognitive functions.

Kanna Extract's Impact on VMAT2

A study investigating a high-mesembrine Sceletium extract, known as Trimesemine™, revealed that treatment with this extract led to a significant upregulation of VMAT2 expression. This upregulation was accompanied by a downregulation of the serotonin transporter (SERT), suggesting that kanna extract may enhance the storage and release of monoamines while simultaneously inhibiting their reuptake. These dual actions could contribute to the mood-lifting effects associated with kanna extract. 

Implications of VMAT2 Upregulation

While VMAT2 upregulation might suggest increased neurotransmitter availability, it's essential to understand the broader context. Research indicates that elevated VMAT2 levels can protect against neurotoxic effects of substances like methamphetamine without enhancing their rewarding effects. This protective mechanism suggests that VMAT2 upregulation may serve as a compensatory response to maintain neurotransmitter balance, rather than solely enhancing mood or cognitive function.

Conclusion

Kanna extract's influence on VMAT2 and SERT highlights its potential as a modulator of neurotransmitter systems, contributing to its traditional use as a mood enhancer. However, the upregulation of VMAT2 appears to be a complex, compensatory mechanism rather than a straightforward enhancement of neurotransmitter activity. As with any supplement, it's crucial to approach kanna extract with an understanding of its multifaceted effects and to consult with healthcare professionals when considering its use.

This article was inspired by discussions on the r/Kanna subreddit.

 https://www.reddit.com/r/Kanna/comments/1iptduw/kanna_is_not_a_vmat2_upregulator/